Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Use of Platelet-Rich Plasma (PRP) and Platelet-Poor Plasma (PPP) to Prevent Infection and Delayed Wound Healing (PRP)

This study has been completed.
Information provided by (Responsible Party):
Gary M. Kiebzak, Ph.D., UHZ Sports Medicine Institute Identifier:
First received: July 10, 2012
Last updated: May 21, 2015
Last verified: May 2015
The purpose of this study is to see if applying PRP and PPP to surgical sites and the closing incision helps prevent infection and slow wound healing.

Condition Intervention
Elective Foot and Ankle Surgery.
Biological: PRP and PPP

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Participant)
Primary Purpose: Prevention
Official Title: Use of Platelet-Rich Plasma (PRP) and Platelet-Poor Plasma (PPP) to Prevent Infection and Delayed Wound Healing After Elective Foot and Ankle Surgery in Healthy Adults

Resource links provided by NLM:

Further study details as provided by UHZ Sports Medicine Institute:

Primary Outcome Measures:
  • Postoperative Infection and Delayed Wound Healing. [ Time Frame: Infection: 30 days after surgery. Delayed wound healing: 60 days. ]
    Postoperative deep incisional surgical site infection and delayed wound healing (lack of primary healing of skin edges typically with wound secretion).

Enrollment: 515
Study Start Date: July 2012
Study Completion Date: March 2015
Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Receiving PRP and PPP.
Administration of PRP and PPP to surgical site.
Biological: PRP and PPP
Autogenous PRP and PPP
No Intervention: Control
Group not receiving autogenous PRP and PPP.

Detailed Description:
This will be a prospective, randomized study with patients blinded to either receiving platelet-rich plasma (PRP) and platelet-poor plasma (PPP) treatment or no treatment. We hypothesize that the antimicrobial properties of PRP and barrier properties of PPP (acting like a tissue sealant) will serve to inhibit deep incisional surgical site infection and help prevent delayed wound healing within 60 days of surgery. Thus, the incidence of infection and delayed wound healing will be lower in patients receiving PRP and PPP compared to patients who do not receive PRP and PPP. However, due to clinical equipoise, we do not know for certain that PRP and PPP is truly effective. The cost of preparing PRP and PPP is substantial, and involves a blood draw that would not otherwise be done. Thus, it is important to know if this treatment is effective or not.

Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Elective foot and ankle surgery.

Exclusion Criteria:

  • Younger than 18 years, older than 80 years of age.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01639144

United States, Florida
UHZ Sports Medicine Institute
Coral Gables, Florida, United States, 33146
Sponsors and Collaborators
Gary M. Kiebzak, Ph.D.
Study Director: Gary M Kiebzak, Ph.D. Center for Research & Grants
  More Information

Responsible Party: Gary M. Kiebzak, Ph.D., Clinical Research Administrator, UHZ Sports Medicine Institute Identifier: NCT01639144     History of Changes
Other Study ID Numbers: 12-024
Study First Received: July 10, 2012
Results First Received: April 6, 2015
Last Updated: May 21, 2015

Keywords provided by UHZ Sports Medicine Institute:
delayed wound healing
platelet-rich plasma

Additional relevant MeSH terms:
Infection processed this record on May 22, 2017